Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2018 Mar-2017 Mar-2016 Mar-2015
Growth matrix (%)        
Revenue growth (1) 18.40 (6.60) 1.21
Op profit growth (41) 4.08 99.90 (40)
EBIT growth (40) (15) 7,946 (105)
Net profit growth 10.70 (63) (590) (73)
Profitability ratios (%)        
OPM 6.70 11.20 12.70 5.95
EBIT margin 9.06 14.90 20.90 0.24
Net profit margin 4.44 3.97 12.80 (2.40)
RoCE 5.45 8.48 9.61 0.12
RoNW 0.73 0.67 1.90 (0.40)
RoA 0.67 0.56 1.47 (0.30)
Per share ratios ()        
EPS 1.33 1.20 3.25 --
Dividend per share -- -- -- --
Cash EPS (0.20) (0.10) 2.86 (3.50)
Book value per share 46.30 45 44.40 41.10
Valuation ratios        
P/E 29.20 33.70 11.80 --
P/CEPS (226) (323) 13.40 (3.10)
P/B 0.84 0.90 0.86 0.27
EV/EBIDTA 7.52 4.82 5.66 (3.30)
Payout (%)        
Dividend payout -- -- -- --
Tax payout (40) (40) (30) (84)
Liquidity ratios        
Debtor days 160 183 200 142
Inventory days 77.70 80.60 76.70 65.20
Creditor days (85) (105) (108) (67)
Leverage ratios        
Interest coverage (5.30) (5.50) (7.70) (0.10)
Net debt / equity (0.20) (0.30) (0.10) (0.50)
Net debt / op. profit (3.60) (3.70) (1.80) (13)
Cost breakup ()        
Material costs (58) (57) (52) (63)
Employee costs (16) (14) (13) (13)
Other costs (19) (18) (22) (18)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Revenue 62.80 63.50 53.60 57.40
yoy growth (%) (1) 18.40 (6.60) 1.21
Raw materials (36) (36) (28) (36)
As % of sales 57.70 57.20 52 62.90
Employee costs (10) (8.70) (7.20) (7.60)
As % of sales 16.30 13.70 13.40 13.30
Other costs (12) (11) (12) (10)
As % of sales 19.30 17.90 21.80 17.90
Operating profit 4.21 7.11 6.83 3.42
OPM 6.70 11.20 12.70 5.95
Depreciation (3.20) (2.80) (0.80) (6.10)
Interest expense (1.10) (1.70) (1.40) (1.70)
Other income 4.64 5.14 5.18 2.79
Profit before tax 4.62 7.75 9.74 (1.60)
Taxes (1.80) (3.10) (2.90) 1.31
Tax rate (40) (40) (30) (84)
Minorities and other -- -- -- --
Adj. profit 2.79 4.64 6.85 (0.20)
Exceptional items -- (2.10) -- (1.10)
Net profit 2.79 2.52 6.85 (1.40)
yoy growth (%) 10.70 (63) (590) (73)
NPM 4.44 3.97 12.80 (2.40)
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Profit before tax 4.62 7.75 9.74 (1.60)
Depreciation (3.20) (2.80) (0.80) (6.10)
Tax paid (1.80) (3.10) (2.90) 1.31
Working capital 23.40 (23) -- 22.70
Other operating items -- -- -- --
Operating cashflow 23.10 (21) 6.02 16.40
Capital expenditure (64) 16.30 -- (16)
Free cash flow (41) (4.60) 6.02 0.10
Equity raised 141 137 138 141
Investments 30.60 2.62 -- (2.60)
Debt financing/disposal (17) (18) -- 17.90
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 114 117 144 156
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2018 Mar-2017 Mar-2016 Mar-2015
Equity capital 21 21 21 21
Preference capital -- -- -- --
Reserves 76.50 73.70 72.40 65.50
Net worth 97.50 94.70 93.40 86.60
Minority interest
Debt 5.98 10.70 24.20 28.60
Deferred tax liabilities (net) -- -- -- --
Total liabilities 103 105 118 115
Fixed assets 10.10 15.40 14.70 4.87
Intangible assets
Investments 30.60 12.70 12.20 10.10
Deferred tax asset (net) 0.76 0.66 0.05 0.09
Net working capital 40.70 39.90 54.20 27.90
Inventories 13.70 13 15 7.52
Inventory Days 79.70 75 102 47.80
Sundry debtors 26 29.20 34.30 24.50
Debtor days 151 168 234 156
Other current assets 18.90 17.80 31.50 9.12
Sundry creditors (13) (14) (19) (9)
Creditor days 77.20 80.20 127 57.40
Other current liabilities (4.70) (6.20) (8) (4.20)
Cash 21.30 36.70 36.60 72.10
Total assets 103 105 118 115
Switch to
Consolidated
Standalone


Alpa Laboratories Ltd Report not showing data